BELIEVE, GLP-1/GIP Agonists, and CATALYST Results at ADA 2025
Update: 2025-07-16
Description
In this episode of Diabetes Dialogue, cohosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and co-director of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, continue their recap of ADA’s 2025 Scientific Sessions, spotlighting 3 more of the top clinical trials focused on obesity and type 2 diabetes.
00:00:00 Intro
00:00:31 BELIEVE Trial
00:08:11 Phase 2 Maritide Trial
00:17:12 CATALYST-2
00:00:00 Intro
00:00:31 BELIEVE Trial
00:08:11 Phase 2 Maritide Trial
00:17:12 CATALYST-2
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
